Role of PPARs in Trypanosoma cruzi Infection: Implications for Chagas Disease Therapy
Chagas disease, which is caused by Trypanosoma cruzi (T. cruzi), remains a substantial public health concern and an important cause of morbidity and mortality in Latin America. T. cruzi infection causes an intense inflammatory response in diverse tissues by triggering local expression of inflammator...
Saved in:
Main Authors: | Eugenia Hovsepian, Federico Penas, Gerardo A. Mirkin, Nora B. Goren |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | PPAR Research |
Online Access: | http://dx.doi.org/10.1155/2012/528435 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trypanosoma cruzi Infection and Host Lipid Metabolism
by: Qianqian Miao, et al.
Published: (2014-01-01) -
Recombinant Enolase of Trypanosoma cruzi as a Novel Vaccine Candidate against Chagas Disease in a Mouse Model of Acute Infection
by: Minerva Arce-Fonseca, et al.
Published: (2018-01-01) -
Alternative transmission modes for Trypanosoma cruzi
by: Christopher M. Kribs-Zaleta
Published: (2010-05-01) -
Immune Evasion Strategies of Trypanosoma cruzi
by: Ana Flávia Nardy, et al.
Published: (2015-01-01) -
The Role of Heme and Reactive Oxygen Species in Proliferation and Survival of Trypanosoma cruzi
by: Marcia Cristina Paes, et al.
Published: (2011-01-01)